Mizuho Kalabis (Mizuho Fukunaga-Kalabis)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Advanced Non Small Cell Lung Cancer

Basal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jason John Luke, Paolo Antonio Ascierto, Muhammad A Khattak, Luis de la Cruz Merino, Michele Del Vecchio, Piotr Lukasz Rutkowski, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion Sileni, Joanne M Jeter, Caroline Robert, Jean-Jacques Grob, Federica de Galitiis, Dirk Schadendorf, Matteo S Carlino, Xi Lawrence Wu, Mizuho Kalabis, Clemens Krepler, Alexander M M Eggermont, Georgina V Long
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Catherine Cohen, Virginie Flouret, Meenhard Herlyn, Mizuho Kalabis, Ling Li, Françoise Bernerd
Induced Pluripotent Stem Cells (iPSC) reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model. Pigment cell & melanoma research (2022)
Cathy Anne Pinto, Xinyue Liu, Xiaoyun Nicole Li, Emilie Scherrer, Mizuho Kalabis
Treatment and overall survival among anti-PD-1-exposed advanced melanoma patients with evidence of disease progression. Immunotherapy (2021)